HBV infection potentiates resistance to S-phase arrest-inducing chemotherapeutics by inhibiting CHK2 pathway in diffuse large B-cell lymphoma

A considerable number of diffuse large B-cell lymphoma (DLBCL) patients are infected with hepatitis B virus (HBV), which is correlated with their poor outcomes. However, the role of HBV infection in DLBCL treatment failure remains poorly understood. Here, our data demonstrated that HBV infection was...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Xinying, Guo, Xudong, Xing, Libo, Yue, Wenqin, Yin, Haisen, He, Miaoxia, Wang, Jianmin, Yang, Jianmin, Chen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833392/
https://www.ncbi.nlm.nih.gov/pubmed/29352124
http://dx.doi.org/10.1038/s41419-017-0097-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5833392/
https://www.ncbi.nlm.nih.gov/pubmed/29352124
http://dx.doi.org/10.1038/s41419-017-0097-1

Ejemplares similares